Clinical Trial Update: A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating cemiplimab plus chemotherapy, comparing a standard combination with an augmented regimen including addi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cemiplimab (cemiplimab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: RECRUITING